By Dean Seal
CV Sciences has agreed to acquire fellow CBD products maker Extract Labs for $1 million in newly issued common stock and $400,000 in cash.
The San Diego-based company said Thursday that the acquisition should grow its sales and client base.
Under the terms of the deal, the sellers of Extract Labs are eligible to receive up to $600,000 in additional CV Sciences stock if certain revenue targets are satisfied in the next two years.
The acquisition is expected to close in the first quarter.
Write to Dean Seal at dean.seal@wsj.com
(END) Dow Jones Newswires
November 21, 2024 16:58 ET (21:58 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。